Dr. Kathleen King

Anne Wojcicki : How to Build the Future

Anne Wojcicki, William Brangham, Dr. Kathleen King

Anne Wojcijk founded 23andMe to democratize genomic data by shifting healthcare incentives from illness monetization to preventative health, despite initial skepticism from medical professionals regarding direct-to-consumer genetic testing. Overcoming early market volatility and a regulatory transition, the company now boasts a community of over five million customers and has secured FDA approvals to leverage its massive dataset for drug discovery and large-scale intervention studies. This persistent execution of a decade-long vision aims to eventually enable personalized longevity strategies by linking genetic profiles with environmental factors like diet and exercise.